Ladenburg Thalmann Financial Services’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $16K | Sell |
1,574
-3,589
| -70% | -$36.5K | ﹤0.01% | 4269 |
|
|
2019
Q3 | $49K | Buy |
5,163
+294
| +6% | +$2.79K | ﹤0.01% | 3476 |
|
|
2019
Q2 | $58K | Buy |
4,869
+2,591
| +114% | +$30.9K | ﹤0.01% | 3362 |
|
|
2019
Q1 | $40K | Buy |
2,278
+1,187
| +109% | +$20.8K | ﹤0.01% | 3564 |
|
|
2018
Q4 | $19K | Hold |
1,091
| – | – | ﹤0.01% | 3912 |
|
|
2018
Q3 | $16K | Hold |
1,091
| – | – | ﹤0.01% | 4052 |
|
|
2018
Q2 | $16K | Hold |
1,091
| – | – | ﹤0.01% | 3979 |
|
|
2018
Q1 | $16K | Hold |
1,091
| – | – | ﹤0.01% | 3979 |
|
|
2017
Q4 | $16K | Hold |
1,091
| – | – | ﹤0.01% | 3938 |
|
|
2017
Q3 | $16K | Hold |
1,091
| – | – | ﹤0.01% | 3822 |
|
|
2017
Q2 | $17K | Sell |
1,091
-933
| -46% | -$14.5K | ﹤0.01% | 3716 |
|
|
2017
Q1 | $28K | Sell |
2,024
-241
| -11% | -$3.33K | ﹤0.01% | 3331 |
|
|
2016
Q4 | $40K | Hold |
2,265
| – | – | ﹤0.01% | 3020 |
|
|
2016
Q3 | $43K | Buy |
2,265
+84
| +4% | +$1.6K | ﹤0.01% | 2899 |
|
|
2016
Q2 | $42K | Buy |
2,181
+42
| +2% | +$809 | ﹤0.01% | 2817 |
|
|
2016
Q1 | $46K | Buy |
2,139
+536
| +33% | +$11.5K | ﹤0.01% | 2662 |
|
|
2015
Q4 | $33K | Hold |
1,603
| – | – | ﹤0.01% | 2882 |
|
|
2015
Q3 | $26K | Hold |
1,603
| – | – | ﹤0.01% | 2943 |
|
|
2015
Q2 | $31K | Buy |
1,603
+81
| +5% | +$1.57K | ﹤0.01% | 2937 |
|
|
2015
Q1 | $29K | Buy |
1,522
+122
| +9% | +$2.33K | ﹤0.01% | 2953 |
|
|
2014
Q4 | $23K | Sell |
1,400
-1,600
| -53% | -$26.3K | ﹤0.01% | 2906 |
|
|
2014
Q3 | $53K | Sell |
3,000
-495
| -14% | -$8.75K | ﹤0.01% | 2000 |
|
|
2014
Q2 | $72K | Sell |
3,495
-585
| -14% | -$12.1K | ﹤0.01% | 1811 |
|
|
2014
Q1 | $89K | Buy |
4,080
+162
| +4% | +$3.53K | ﹤0.01% | 1578 |
|
|
2013
Q4 | $104K | Sell |
3,918
-10
| -0.3% | -$265 | ﹤0.01% | 1462 |
|
|
2013
Q3 | $93K | Buy |
3,928
+53
| +1% | +$1.26K | ﹤0.01% | 1440 |
|
|
2013
Q2 | $83K | Buy |
+3,875
| New | +$83K | ﹤0.01% | 1415 |
|